Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: prvtinvest who wrote (12196)	7/8/2013 11:30:20 AM
From: Mimbari	2 Recommendations Recommended By Jack Russell mplaut Read Replies (1) \| Respond to of 13111

Agreed. I just don't care for someone stating how things should be when their own credentials have not been forthcoming. It would be like me saying that any drug inventor should do a quadruple arm study while hopping on one foot. Who am I to say how a study should be designed, run and results given? NTTG's attitude on this is thinking the best balanced position is to have a chip on both shoulders. But I have seen the results of two patients in person. That was enough for me.